Nothing Special   »   [go: up one dir, main page]

MA40170A - Dérivés hétérocycliques de morphinan et leur utilisation - Google Patents

Dérivés hétérocycliques de morphinan et leur utilisation

Info

Publication number
MA40170A
MA40170A MA040170A MA40170A MA40170A MA 40170 A MA40170 A MA 40170A MA 040170 A MA040170 A MA 040170A MA 40170 A MA40170 A MA 40170A MA 40170 A MA40170 A MA 40170A
Authority
MA
Morocco
Prior art keywords
heterocyclic
morphinan derivatives
morphinan
derivatives
solvates
Prior art date
Application number
MA040170A
Other languages
English (en)
Inventor
Laykea Tafesse
Mark A Youngman
Original Assignee
Purdue Pharma Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Pharma Lp filed Critical Purdue Pharma Lp
Publication of MA40170A publication Critical patent/MA40170A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La présente invention concerne des composés de formule (i) et des sels et solvates pharmaceutiquement acceptables de ceux-ci. Dans la formule (i), r
MA040170A 2014-06-13 2015-06-12 Dérivés hétérocycliques de morphinan et leur utilisation MA40170A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462011696P 2014-06-13 2014-06-13

Publications (1)

Publication Number Publication Date
MA40170A true MA40170A (fr) 2017-04-19

Family

ID=54834422

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040170A MA40170A (fr) 2014-06-13 2015-06-12 Dérivés hétérocycliques de morphinan et leur utilisation

Country Status (6)

Country Link
US (1) US10131666B2 (fr)
EP (1) EP3154971A4 (fr)
JP (2) JP2017521488A (fr)
CA (1) CA2952124A1 (fr)
MA (1) MA40170A (fr)
WO (1) WO2015192039A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2890655A1 (fr) 2012-11-09 2014-05-15 Purdue Pharma L.P. Analogues de benzomorphane et leur utilisation
EP3087078B1 (fr) 2013-12-26 2019-05-15 Purdue Pharma LP Analogues 7-bêta-alkyle d'orvinols
EP3087079B1 (fr) 2013-12-26 2019-04-03 Purdue Pharma LP Morphinanes oxabicyclo[2.2.2]octane modulateurs des récepteurs aux opiacés
EP3087073B1 (fr) 2013-12-26 2018-07-04 Purdue Pharma LP Hydantoïnes de morphinane substitués en position 10
WO2015100174A1 (fr) 2013-12-26 2015-07-02 Purdue Pharma L.P. Morphinanes à cycle contracté et leur utilisation
EP3086790A4 (fr) 2013-12-27 2017-07-19 Purdue Pharma LP Analogues de la morphinane 6-substitués et 7-substitués, et leurs utilisations
US10202382B2 (en) 2014-06-13 2019-02-12 Purdue Pharma L.P. Azamorphinan derivatives and use thereof
MA41125A (fr) 2014-12-05 2017-10-10 Purdue Pharma Lp Dérivés de 6.7-cyclomorphinane et leur utilisation
CN108602777B (zh) 2016-01-13 2022-05-03 格吕伦塔尔有限公司 3-((杂-)芳基)-烷基-8-氨基-2-氧代-1，3-氮杂-螺-[4.5]-癸烷衍生物
SI3402783T1 (sl) 2016-01-13 2020-10-30 Gruenenthal Gmbh Derivati 3-(karboksietil)-8-amino-2-okso-1,3-diaza-spiro-(4.5)-dekana
EP3402781B1 (fr) 2016-01-13 2020-03-04 Grünenthal GmbH Derives de 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane
RS60855B1 (sr) 2016-01-13 2020-10-30 Gruenenthal Gmbh Derivati 8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana
MX2018008646A (es) * 2016-01-13 2018-11-19 Gruenenthal Gmbh Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5] -decano.
WO2018125716A1 (fr) 2017-01-02 2018-07-05 Purdue Pharma L.P. Dérivés de morphinane et leur utilisation
TW201908295A (zh) 2017-07-12 2019-03-01 德商歌林達有限公司 １，３－二氮雜－螺－［３．４］－辛烷衍生物

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991005768A1 (fr) * 1989-10-16 1991-05-02 The United States Of America, Represented By The Secretary, United States Department Of Commerce Synthese totale d'enantiomeres et de derives de northebaine, normorphine, neuroxymorphone par des intermediaires n-nor
IT1270612B (it) * 1994-07-14 1997-05-07 Smithkline Beecham Farma Derivati eterociclo-condensatori di morfinoidi
AR005423A1 (es) * 1996-01-10 1999-06-23 Smithkline Beecham Spa Derivados morfinoides condensados con heterociclos (ii), su uso como sustancia terapeutica y para preparar medicamentos, composiciones farmaceuticasque los contienen y procedimiento para preparar dichos derivados.
IL132522A0 (en) 1997-04-22 2001-03-19 Cocensys Inc Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and pharmaceutical compositions containing the same
JP4070955B2 (ja) 1997-11-21 2008-04-02 ユーロ−セルティーク エス．エイ． 置換２−アミノアセトアミドおよびその使用
US6281211B1 (en) 1999-02-04 2001-08-28 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
CZ20013435A3 (cs) 1999-03-26 2002-04-17 Euro-Celtique S. A. Aryly substituované pyrazoly, imidazoly, oxazoly, thiazoly a pyrroly a jejich pouľití
WO2000061188A1 (fr) 1999-04-09 2000-10-19 Euro-Celtique S.A. Composition de blocage du canal sodique et leur utilisation
AR029489A1 (es) 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
ES2398093T3 (es) 2000-03-24 2013-03-13 Euro-Celtique S.A. Pirazoles, triazoles y tetrazoles sustituidos con arilo como bloqueantes de los canales de sodio
CA2403991A1 (fr) 2000-03-31 2001-10-11 Euro-Celtique S.A. Aminopyridines et leur utilisation en tant qu'anticonvulsants et inhibiteurs du canal sodium
EP1417187A1 (fr) 2001-07-16 2004-05-12 Euro-Celtique S.A. Thiazolidinones a substitution aryle et utilisations
AR037233A1 (es) 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
AR036873A1 (es) 2001-09-07 2004-10-13 Euro Celtique Sa Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
IL163940A0 (en) 2002-03-13 2005-12-18 Euro Celtique Sa Aryl substituted pyrimidines and the use thereof
DE10229842A1 (de) * 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
AU2003257033A1 (en) 2002-07-31 2004-02-16 Euro-Celtique S.A. Aryl substituted benzimidazoles and their use as sodium channel blockers
WO2004010950A2 (fr) 2002-07-31 2004-02-05 Euro-Celtique S.A. Composes hydantoine aryle substitues et utilisation de ces composes comme bloqueurs de canal sodium
US20040152696A1 (en) 2002-08-01 2004-08-05 Euro-Celtique S.A. 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers
WO2005014849A2 (fr) 2003-07-03 2005-02-17 Euro-Celtique, S.A. Genes associes a des reponses a des douleurs neuropathiques
CN101481376A (zh) * 2008-01-10 2009-07-15 中国科学院上海药物研究所 一类杂环并14-羟基-吗啡喃类化合物、制备方法及用途
EP2582666B1 (fr) 2010-06-16 2014-08-13 Purdue Pharma L.P. Indoles à substitution aryle et leur utilisation en tant que bloqueur des canaux sodium
US9120752B2 (en) 2010-07-16 2015-09-01 Purdue Pharma, L.P. Pyridine compounds as sodium channel blockers
KR20130056345A (ko) 2010-09-17 2013-05-29 퍼듀 퍼머 엘피 피리딘 화합물 및 그의 용도
ES2540562T3 (es) 2010-10-05 2015-07-10 Purdue Pharma L.P. Compuestos de quinazolina como bloqueadores de canales de sodio
CN103429571A (zh) 2010-12-22 2013-12-04 普渡制药公司 作为钠通道阻断剂的取代吡啶
PT2753606T (pt) 2011-09-02 2017-10-02 Purdue Pharma Lp Pirimidinas como bloqueadoras dos canais de sódio
WO2013064883A1 (fr) 2011-10-31 2013-05-10 Purdue Pharma L.P. Composés hétéroaryliques comme agents de blocage des canaux sodiques
WO2013064884A1 (fr) 2011-10-31 2013-05-10 Purdue Pharma L.P. Amines quaternisées en tant que bloqueurs des canaux sodiques
WO2013072758A1 (fr) 2011-11-15 2013-05-23 Purdue Pharma L.P. Pyrimidine diol amides comme bloqueurs des canaux sodiques
US9206127B2 (en) 2012-03-16 2015-12-08 Purdue Pharm, L.P. Substituted pyridines as sodium channel blockers
EP2931725B1 (fr) 2012-12-14 2017-02-15 Purdue Pharma LP Dérivés de morphinane contenant de l'azote et leur utilisation
ES2631197T3 (es) * 2012-12-14 2017-08-29 Purdue Pharma Lp Análogos de piridonamorfinano y actividad biológica sobre los receptores opiodes
EP2935257B1 (fr) 2012-12-20 2018-02-07 Purdue Pharma LP Sulfonamides cycliques en tant que bloquants des canaux sodiques
US9120786B2 (en) 2013-03-04 2015-09-01 Purdue Pharma, L.P. Triazine carboxamides as sodium channel blockers
AU2014224310B2 (en) 2013-03-04 2017-02-09 Purdue Pharma L.P. Pyrimidine carboxamides as sodium channel blockers
CA2939549C (fr) 2013-03-15 2020-08-18 Purdue Pharma L.P. Derives de carboxamide et leur utilisation
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
JP6161801B2 (ja) 2013-05-24 2017-07-12 ローズ テクノロジーズ オピオイドケタール化合物及びその使用
US9359330B2 (en) 2013-08-26 2016-06-07 Purdue Pharma L.P. Substituted piperidines as sodium channel blockers
US9828348B2 (en) 2013-11-08 2017-11-28 Purdue Pharma L.P. Benzimidazole derivatives and use thereof
US9340504B2 (en) 2013-11-21 2016-05-17 Purdue Pharma L.P. Pyridine and piperidine derivatives as novel sodium channel blockers
US9695144B2 (en) 2013-12-23 2017-07-04 Purdue Pharma L.P. Dibenzazepine derivatives and use thereof
US9902726B2 (en) * 2013-12-30 2018-02-27 Purdue Pharma L.P. Pyridone-sulfone morphinan analogs as opioid receptor ligands
US10047075B2 (en) 2014-01-24 2018-08-14 Purdue Pharma L.P. Pyridines and pyrimidines and use thereof
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof

Also Published As

Publication number Publication date
EP3154971A4 (fr) 2017-11-01
WO2015192039A1 (fr) 2015-12-17
CA2952124A1 (fr) 2015-12-17
JP2019031519A (ja) 2019-02-28
US10131666B2 (en) 2018-11-20
JP2017521488A (ja) 2017-08-03
EP3154971A1 (fr) 2017-04-19
US20180111934A1 (en) 2018-04-26

Similar Documents

Publication Publication Date Title
MA40170A (fr) Dérivés hétérocycliques de morphinan et leur utilisation
MA40171A (fr) Dérivés d'azamophinan et leur utilisation
PH12019501321B1 (en) Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders
PH12016501972A1 (en) Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors
TW201613872A (en) IRAK4 inhibiting agents
AU2014267235A8 (en) Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
MA40058A (fr) Composés inhibiteurs de kinases se liant à tank
MX2017004200A (es) Compuestos de heteroarilo como inhibidores de tirosina-cinasa de bruton (btk) y usos de estos.
JO3317B1 (ar) مركبات تترا هيدروبيرولو ثيازين
MA39749A (fr) Dérivés de pipéridine-dione
MX2017003930A (es) Derivados de aminotriazina utiles como compuestos inhibidores de la cinasa de union a tank.
CR20150470A (es) Derivados de triazolona de piridinilo y piridinilo fusionado
MX2018001992A (es) Compuestos triciclicos heterociclicos como inhibidores de fosfoinositol 3-quinasa.
MX2018004664A (es) Antagonistas de ep4.
MA39866A (fr) Amides 2-amino-6-méthyl-4,4a,5,6-tétrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yle
MA40250A (fr) Dérivés de quinolizinone utilisés comme inhibiteurs de pi3k
JO3318B1 (ar) مثبطات bace
SA517381678B1 (ar) مركبات داي هيدرو بيريميدين-2-أون واستخدامها الطبي
MX2015013224A (es) Inhibidores macrociclicos y biciclicos del virus de la hepatitis c.
JOP20190163B1 (ar) منشط nrf2
EA201491227A1 (ru) Новые производные морфолинила, подходящие для применения в качестве ингибиторов mogat-2
IN2013MU03862A (fr)
EA201791099A1 (ru) Хинолин карбоксамиды для применения в лечении лейкоза
PH12016501645A1 (en) Aminopyrazolone derivative
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases